169 related articles for article (PubMed ID: 34857857)
1. Analysis at the single-cell level indicates an important role of heterogeneous global DNA methylation status on the progression of lung adenocarcinoma.
Chen QF; Gao H; Pan QY; Wang YJ; Zhong XN
Sci Rep; 2021 Dec; 11(1):23337. PubMed ID: 34857857
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
3. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
5. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Gene; 2021 Jul; 790():145689. PubMed ID: 33964375
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
[TBL] [Abstract][Full Text] [Related]
7. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
9. Elevated Expression of
Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
Zhu XF; Zhu BS; Wu FM; Hu HB
J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.
Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A
Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151
[TBL] [Abstract][Full Text] [Related]
12.
Zhang W; Li T; Hu B; Li H
Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
[TBL] [Abstract][Full Text] [Related]
13. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
14. Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.
Zhang Y; Wu X; Kai Y; Lee CH; Cheng F; Li Y; Zhuang Y; Ghaemmaghami J; Chuang KH; Liu Z; Meng Y; Keswani M; Gough NR; Wu X; Zhu W; Tzatsos A; Peng W; Seto E; Sotomayor EM; Zheng X
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852841
[TBL] [Abstract][Full Text] [Related]
15. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
17. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
18. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Shi S; Xu M; Xi Y
Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
[TBL] [Abstract][Full Text] [Related]
20. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]